Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
3. November 2024
5 min to read

State-of-the-Art Review – From ST-Segment Elevation MI to Occlusion MI: The New Paradigm Shift in Acute Myocardial Infarction

From ST-Segment Elevation MI to Occlusion MI

Overview:

This state-of-the-art review explores the evolution of heart attack classification, challenging the limitations of the standard-of-care STEMI/NSTEMI framework. It advocates for a shift toward diagnosing heart attacks based on the presence of acute vessel occlusion rather than relying solely on standard ECG criteria. By redefining how myocardial infarctions are identified and managed, this approach has the potential to reduce misdiagnoses, optimize triage, and refine treatment prioritization in emergency cardiology.

Published In: Journal of the American College of Cardiology (JACC) – JACC Advances
Presented Date: November 03, 2024

Introduction

A generation ago thrombolytic therapy led to a paradigm shift in myocardial infarction (MI), from Q-wave/non-Q-wave to ST-segment elevation MI (STEMI) vs non-STEMI. Using STE on the electrocardiogram (ECG) as a surrogate marker for acute coronary occlusion (ACO) allowed for rapid diagnosis and treatment. But the vast research catalyzed by the STEMI paradigm has revealed increasing anomalies: 25% of “non-STEMI” have ACO with delayed reperfusion and higher mortality.

Studying these limitations has given rise to the occlusion MI (OMI) paradigm, based on the presence or absence of ACO in the patient rather than STE on ECG. The OMI paradigm shift harnesses advanced ECG interpretation aided by artificial intelligence, complementary bedside echocardiography and advanced imaging, and clinical signs of refractory ischemia, and offers the next opportunity to transform emergency cardiology and improve patient care. This State-of-the-Art Review examines the paradigm shifts from Q wave to STEMI to OMI.

Highlights

  • The STEMI paradigm transformed emergency cardiology, but there is increasing recognition of its limitations.
  • STEMI criteria is a poor surrogate marker for acute coronary occlusion, leading to delayed reperfusion.
  • Evidence-based advances can identify OMI not meeting STEMI criteria, and false positive STEMI.
  • The OMI paradigm harnesses advanced ECG interpretation aided by artificial intelligence, echocardiography, and advanced imaging.

Authors: Jesse McLaren, José Nunes de Alencar, Emre K. Aslanger, H Pendell Meyers, and Stephen W. Smith

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

Artificial intelligence-enhanced ECG detection of acute coronary occlusion in chest pain patients with ST-elevation in lead aVR – A direct comparison to conventional ECG criteria

In a single‑centre retrospective study of 145 consecutive emergency‑department patients whose first ECG showed ≥1 mm ST‑elevation in lead aVR, investigators compared conventional electrocardiographic rules with a deep‑learning classifier (PMcardio “Queen of Hearts”) for recognising an acute coronary occlusion (ACO). Angiography and biomarker adjudication proved ACO in 19 patients (13 %). At an optimised probability threshold, the AI system achieved an area‑under‑the‑ROC curve of 0.918, detected 63 % of occlusions, and—crucially—generated no false‑positive calls in the 54‑patient rule‑out subgroup. By contrast, classic STEMI millimetre criteria identified only one in four occlusions and would have prompted between four and fourteen unnecessary emergency catheterisations.

AI-enhanced recognition of occlusions in acute coronary syndrome (AERO-ACS): a retrospective study

In a one‑year, single‑centre cohort of 217 cath‑lab patients (72 STEMI, 145 NSTEMI), the AERO‑ACS study tested PMcardio’s AI ECG against traditional ST‑elevation rules for detecting angiographic occlusion‑MI. The algorithm matched STEMI sensitivity (86.5 % vs 83.3 %) while raising specificity to 82.2 % (vs 66.0 %), achieved 100 % sensitivity in STEMI cases, and flagged occlusions linked to a 12‑fold higher in‑hospital mortality risk—suggesting more accurate triage with fewer unnecessary activations.

Join over 100,000 healthcare professionals who are already taking advantage of AI